Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Connective Tissue Cell Types

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...

Inflammatory Response I: Vascular and Cellular

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

When Tears Stop Flowing: A Unilateral Dry Eye in a 35-Year-Old Man.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026

Same author

Pupillary disorders.

Handbook of clinical neurology·2026

Same author

Acute Orbital Inflammatory Syndrome and Vision Loss After Aminobisphosphonate Infusion.

Neuro-ophthalmology (Aeolus Press)·2026

Same author

Reduced pupil light response to red light correlates with cone defect in Rho<sup>-/-</sup> mice.

Experimental eye research·2025

Same author

Hyperreflective Dots (HRDs) in Two Patients with Nonarteritic Anterior Ischemic Optic Neuropathy (NAION).

Klinische Monatsblatter fur Augenheilkunde·2025

Same author

National Conference of Neuro-Ophthalmology in Chandigarh India February 7-9, 2025.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2025

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Giant cell arteritis: an updated review.

Aki Kawasaki¹, Valerie Purvin

¹Department of Neuro-ophthalmology, Hôpital Ophtalmique Jules Gonin, Lausanne, Switzerland. aki.kawasaki@ophtal.vd.ch

Acta Ophthalmologica

|October 22, 2008

Summary

This summary is machine-generated.

Giant cell arteritis (GCA) is a common vasculitis affecting older adults, primarily impacting vision. Early steroid treatment is crucial to prevent vision loss and other complications.

Related Experiment Videos

Last Updated: Jun 28, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Area of Science:

Rheumatology
Ophthalmology
Immunology

Background:

Giant cell arteritis (GCA) is the most prevalent primary vasculitis in adults.
Its incidence increases significantly with age, with a median onset around 75 years.
Ophthalmologists require familiarity with GCA's ophthalmic and non-ophthalmic manifestations due to the aging population.

Purpose of the Study:

To review current understanding of GCA immunopathogenesis.
To discuss major phenotypic subtypes, focusing on large vessel vasculitis.
To explore novel diagnostic methods and non-steroid therapeutic trials for GCA.

Main Methods:

Literature review of immunopathogenetic pathways in GCA.
Analysis of phenotypic variations, particularly large vessel involvement.
Examination of emerging diagnostic tools and alternative treatments.

Main Results:

Prompt corticosteroid initiation is key to preventing ischemic complications.
Understanding immunopathogenesis aids in identifying therapeutic targets.
Novel detection methods and non-steroid therapies are under investigation.

Conclusions:

Heightened awareness of GCA is essential for timely diagnosis and treatment.
Effective management strategies focus on early steroid intervention and exploring new therapies.
Continued research into GCA pathogenesis and treatment is vital for improving patient outcomes.